comparemela.com

Page 3 - Res Ther News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Although phase 2 data suggested baricitinib as a potential treatment for patients with SLE, which was supported in SLE-BRAVE-I, this result was not replicated in SLE-BRAVE-II. No new safety signals were observed.

A New Paradigm for Testing Psychiatric Drugs Is Needed

Higher fasting blood sugar worsens knee symptoms in patients with knee osteoarthritis

Japan: A recent study in Arthritis Research & Therapy has shown that higher blood sugar levels in patients with radiographic knee osteoarthritis (KOA) and central sensitization (CS) are associated.

Systemic sclerosis

Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue disease. Once considered an untreatable and unpredictable condition, research advancements have improved our understanding of its disease pathogenesis and clinical phenotypes and expanded our treatment armamentarium. Early and accurate diagnosis is essential, while ongoing efforts to risk stratify patients have a central role in predicting both organ involvement and disease progression. A holistic approach is required when choosing the optimal therapeutic strategy, balancing the side-effect profile with efficacy and tailoring the treatment according to the goals of care of the patient.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.